« Back to Record
Citation APA

Biganzoli, L., Cufer, T., Bruning, P., Coleman, R., Duchateau, L., Calvert, A. H., Gamucci, T., Twelves, C., Fargeot, P., Epelbaum, R., Lohrisch, C., & Piccart-Gebhart, M. (2002). Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial. Journal of clinical oncology, 20(14), 3114-3121.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55266

Biganzoli, L., Cufer, T., Bruning, P., Coleman, R., Duchateau, L., Calvert, A. H., Gamucci, T., Twelves, C., Fargeot, P., Epelbaum, R., Lohrisch, C., & Piccart-Gebhart, M. (2002). Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial. Journal of clinical oncology, 20(14), 3114-3121.